FDA considers first psychedelic drug approval

The FDA held a public hearing on the future therapeutic use of psychedelic drugs, as biotech companies report successful phase 3 trials for psilocybin and LSD. The hearing revealed deep divisions over access, safety oversight, and whether politics is outpacing science.